JP2025063321A5 - - Google Patents
Info
- Publication number
- JP2025063321A5 JP2025063321A5 JP2025011527A JP2025011527A JP2025063321A5 JP 2025063321 A5 JP2025063321 A5 JP 2025063321A5 JP 2025011527 A JP2025011527 A JP 2025011527A JP 2025011527 A JP2025011527 A JP 2025011527A JP 2025063321 A5 JP2025063321 A5 JP 2025063321A5
- Authority
- JP
- Japan
- Prior art keywords
- hla
- amino acid
- seq
- acid sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813647P | 2019-03-04 | 2019-03-04 | |
| US62/813,647 | 2019-03-04 | ||
| JP2021552604A JP2022524993A (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
| PCT/IB2020/051811 WO2020178742A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552604A Division JP2022524993A (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025063321A JP2025063321A (ja) | 2025-04-15 |
| JP2025063321A5 true JP2025063321A5 (https=) | 2025-12-18 |
| JP7825752B2 JP7825752B2 (ja) | 2026-03-06 |
Family
ID=72337382
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552604A Withdrawn JP2022524993A (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
| JP2025011527A Active JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552604A Withdrawn JP2022524993A (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220152105A1 (https=) |
| EP (1) | EP3935177A4 (https=) |
| JP (2) | JP2022524993A (https=) |
| KR (1) | KR20210144740A (https=) |
| CN (1) | CN113795585B (https=) |
| AU (1) | AU2020231107A1 (https=) |
| BR (1) | BR112021017467A2 (https=) |
| CA (1) | CA3132434A1 (https=) |
| IL (1) | IL286041A (https=) |
| MX (1) | MX2021010539A (https=) |
| SG (1) | SG11202109593SA (https=) |
| TW (1) | TWI877144B (https=) |
| WO (1) | WO2020178742A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE058957T2 (hu) | 2016-12-08 | 2022-10-28 | Immatics Biotechnologies Gmbh | Új T-sejt receptorok és velük végzett immunterápia |
| JP7748284B2 (ja) | 2019-03-04 | 2025-10-02 | ユニバーシティー ヘルス ネットワーク | Ｔ細胞受容体及びその使用方法 |
| MX2021010541A (es) | 2019-03-04 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| CN113795586B (zh) | 2019-03-25 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
| CN112239495B (zh) * | 2020-10-29 | 2022-04-12 | 上海药明生物技术有限公司 | 稳定的tcr结构及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008206442B2 (en) * | 2007-01-12 | 2012-10-18 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | gp100-specific T cell receptors and related materials and methods of use |
| US9051391B2 (en) * | 2007-06-11 | 2015-06-09 | Takara Bio Inc. | Method for expression of specific gene |
| WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| US11396536B2 (en) * | 2016-04-27 | 2022-07-26 | University Health Network | Peptide-HLA complexes and methods of producing same |
-
2020
- 2020-03-03 CN CN202080025290.9A patent/CN113795585B/zh active Active
- 2020-03-03 BR BR112021017467A patent/BR112021017467A2/pt unknown
- 2020-03-03 MX MX2021010539A patent/MX2021010539A/es unknown
- 2020-03-03 WO PCT/IB2020/051811 patent/WO2020178742A1/en not_active Ceased
- 2020-03-03 AU AU2020231107A patent/AU2020231107A1/en active Pending
- 2020-03-03 KR KR1020217031553A patent/KR20210144740A/ko active Pending
- 2020-03-03 EP EP20767178.5A patent/EP3935177A4/en active Pending
- 2020-03-03 US US17/436,936 patent/US20220152105A1/en active Pending
- 2020-03-03 SG SG11202109593S patent/SG11202109593SA/en unknown
- 2020-03-03 CA CA3132434A patent/CA3132434A1/en active Pending
- 2020-03-03 JP JP2021552604A patent/JP2022524993A/ja not_active Withdrawn
- 2020-03-04 TW TW109107110A patent/TWI877144B/zh active
-
2021
- 2021-09-01 IL IL286041A patent/IL286041A/en unknown
-
2025
- 2025-01-27 JP JP2025011527A patent/JP7825752B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025063321A5 (https=) | ||
| JP7223822B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ６ ｔ細胞受容体 | |
| JP7270001B2 (ja) | Ｍｈｃクラスｉｉ拘束性ｍａｇｅ－ａ３を認識するｔ細胞受容体 | |
| JP2022050400A5 (https=) | ||
| AU2017371260B2 (en) | T cell receptors with improved pairing | |
| CN111201237B (zh) | 针对突变的ras的hlaii类限制性t细胞受体 | |
| JP6863893B2 (ja) | 抗突然変異ｋｒａｓ ｔ細胞受容体 | |
| JP2021500855A5 (https=) | ||
| CN111836638A (zh) | 针对突变的ras的hla i类限制性t细胞受体 | |
| JP2020511949A5 (https=) | ||
| JP2023133505A5 (https=) | ||
| JP7735285B2 (ja) | Ｇ１２ｖ突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 | |
| JP2021521793A5 (https=) | ||
| JPWO2020063488A5 (https=) | ||
| JP7742354B2 (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2025114614A (ja) | Ｇ１２ｒ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2023534241A (ja) | Ｇ１２ｄ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 | |
| JPWO2020194195A5 (https=) | ||
| JPWO2020178739A5 (https=) | ||
| CN116348484A (zh) | 针对含有g12v突变的ras的hla-ii类限制性drb t细胞受体 | |
| JPWO2020178738A5 (https=) | ||
| JPWO2020178742A5 (https=) | ||
| JPWO2020178740A5 (https=) | ||
| JPWO2020178741A5 (https=) | ||
| HK40061898A (en) | T cell receptors recognizing mhc class ii-restricted mage-a3 |